2023.02.09

Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange

16 February 2023 – the date for Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange. We have great pleasure to invite all ...
2023.01.25

Polish Financial Supervision Authority approved the Genomtec S.A. prospectus

In the next few days, the company expects to apply to the Warsaw Stock Exchange for admission and listing of Genomtec S.A. shares on the Warsaw ...
2023.01.10

Value of the intellectual property portfolio of Genomtec S.A. estimated at EUR 191.336 million

Genomtec S.A. received from the German company Dennemeyer Consulting GmbH a valuation of the Company’s intellectual property portfolio. ...
2022.11.30

Genomtec S.A. signs an agreement with transaction advisor Clairfield Partners LLC

Genomtec S.A., a medical technology company specializing in the development of advanced technologies in the field of genetic diagnostics, has ...
2022.08.10

Genomtec wins a new partner to commercialize the Genomtec® ID platform in Taiwan (R.O.C.).

Genomtec has signed up a new Partner for the commercialization of its flagship Genomtec® ID genetic testing platform and the Respiratory Panel ...
2022.07.11

Genomtec appoints new Chief Technology Officer

Genomtec has appointed Richard Moore as the new Chief Technology Officer to drive its next generation of products and systems. Richard replaces ...